{"id":"W3150954884","doi":"10.1007/s12185-021-03126-6","title":"Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia","year":2021,"lang":"en","type":"review","venue":"International Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Imatinib; Myeloid leukemia; Medicine; Druggability; Tyrosine kinase; Tyrosine-kinase inhibitor; Dasatinib; Homoharringtonine; Oncology; Hematology; Pharmacology; Adverse effect; Chronic myelogenous leukemia; Cancer research; Leukemia; Cancer; Internal medicine; Biology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003915443,0.0004240459,0.002791568,0.0006811008,0.00002376627,0.00001654817,0.0007951184,0.0004243743,0.0006118923],"category_scores_gemma":[0.0004996827,0.0002764102,0.001194901,0.0004218551,0.0001976804,0.00008818546,0.0002932629,0.00123608,0.00002703844],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.009000348,"about_ca_system_score_gemma":0.01056777,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007359604,"about_ca_topic_score_gemma":0.00006097979,"domain_scores_codex":[0.9960862,0.0002685137,0.002159115,0.000316975,0.0008328345,0.000336365],"domain_scores_gemma":[0.9965567,0.0003352526,0.002154982,0.0004488569,0.0003864027,0.0001177854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006339344,0.002483898,0.008059278,0.03004896,0.01531554,0.0418141,0.0005728248,0.0002925047,0.000418158,0.01424304,0.02869626,0.8574215],"study_design_scores_gemma":[0.003992149,0.0003144192,0.0001555684,0.05335177,0.0009384013,0.03781682,0.0000300147,0.00002392082,0.002084333,0.0002722747,0.9007618,0.0002585194],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002048058,0.9933978,0.00001730822,0.0009191612,0.002679549,0.0003988284,0.00003682075,0.000006902239,0.0004956242],"genre_scores_gemma":[0.007472715,0.9904797,0.0003799633,0.00009483765,0.0009751999,0.00001597246,0.00006768042,0.00006195551,0.0004519389],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8720655,"threshold_uncertainty_score":0.9999688,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0223135065839013,"score_gpt":0.3286523114547571,"score_spread":0.3063388048708558,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}